Takhzyro 150 MG

Ended Awarded Last action

Contract number
36C24526N0825
Awardee
Awarding agency
Obligated
$38,098

Award facts

Contract value 100% obligated
$38,097.52 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Brooks, KY 40109, USA

Award details come from SAM.gov/FPDS.

About this award

Veterans Integrated Service Network 5 issued a BPA call to Takeda Pharmaceuticals America, Inc. for TAKHZYRO 150 mg with a ceiling value of $38,097.52, awarded August 20, 2026 and completed August 25, 2026.

The call was placed under a single-award Blanket Purchase Agreement with the VA National Acquisition Center for ICLUSIG (ponatinib), a targeted oncology pharmaceutical. Performance occurs at Brooks, Kentucky. Takeda is a large, foreign-owned manufacturer with no small business designations, competing on a full-and-open basis through the GSA Pharmaceuticals and Drugs Federal Supply Schedule.

Quick answers

Who was awarded contract 36C24526N0825?

36C24526N0825 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 20, 2026.

How much is contract 36C24526N0825 worth?

The government has obligated $38,098 on 36C24526N0825.

Is contract 36C24526N0825 an order under another contract?

Yes. 36C24526N0825 is a BPA call under 36F79726D031E-36E79726A0012, a blanket purchase agreement.

Was contract 36C24526N0825 competed?

The extent of competition for 36C24526N0825 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award